{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T20:03:26Z","timestamp":1792872206647,"version":"4.5.0"},"reference-count":74,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2019,5,19]],"date-time":"2019-05-19T00:00:00Z","timestamp":1558224000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,5,19]],"date-time":"2019-05-19T00:00:00Z","timestamp":1558224000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001824","name":"Grantov\u00e1 Agentura \u010cesk\u00e9 Republiky","doi-asserted-by":"publisher","award":["17-07585Y"],"award-info":[{"award-number":["17-07585Y"]}],"id":[{"id":"10.13039\/501100001824","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007543","name":"Grantov\u00e1 Agentura, Univerzita Karlova","doi-asserted-by":"publisher","award":["34119"],"award-info":[{"award-number":["34119"]}],"id":[{"id":"10.13039\/100007543","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1007\/s00210-019-01665-8","type":"journal-article","created":{"date-parts":[[2019,5,19]],"date-time":"2019-05-19T23:16:54Z","timestamp":1558307814000},"page":"1209-1223","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["In vitro effects of antipsychotics on mitochondrial respiration"],"prefix":"10.1007","volume":"392","author":[{"given":"Tereza","family":"Cik\u00e1nkov\u00e1","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zden\u011bk","family":"Fi\u0161ar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yousra","family":"Bakhouche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matej","family":"\u013dupt\u00e1k","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jana","family":"Hroudov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,5,19]]},"reference":[{"key":"1665_CR1","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.neulet.2010.10.037","volume":"487","author":"FR Agostinho","year":"2011","unstructured":"Agostinho FR, R\u00e9us GZ, Stringari RB, Ribeiro KF, Ferraro AK, Benedet J, Rochi N, Scaini G, Streck EL, Quevedo J (2011) Treatment with olanzapine, fluoxetine and olanzapine\/fluoxetine alters citrate synthase activity in rat brain. Neurosci Lett 487:278\u2013281. https:\/\/doi.org\/10.1016\/j.neulet.2010.10.037","journal-title":"Neurosci Lett"},{"key":"1665_CR2","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/S0028-3908(98)00215-9","volume":"38","author":"S Balijepalli","year":"1999","unstructured":"Balijepalli S, Boyd MR, Ravindranath V (1999) Inhibition of mitochondrial complex I by haloperidol: the role of thiol oxidation. Neuropharmacology 38:567\u2013577","journal-title":"Neuropharmacology"},{"key":"1665_CR3","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1192\/bjp.186.1.7","volume":"186","author":"AA Bolonna","year":"2005","unstructured":"Bolonna AA, Kerwin RW (2005) Partial agonism and schizophrenia. Br J Psychiatry 186:7\u201310. https:\/\/doi.org\/10.1192\/bjp.186.1.7","journal-title":"Br J Psychiatry"},{"key":"1665_CR4","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1002\/ana.410330516","volume":"33","author":"C Burkhardt","year":"1993","unstructured":"Burkhardt C, Kelly JP, Lim YH, Filley CM, Parker WD (1993) Neuroleptic medications inhibit complex I of the electron transport chain. Ann Neurol 33:512\u2013517. https:\/\/doi.org\/10.1002\/ana.410330516","journal-title":"Ann Neurol"},{"key":"1665_CR5","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1097\/JCP.0b013e318054753e","volume":"27","author":"J Casademont","year":"2007","unstructured":"Casademont J, Garrabou G, Mir\u00f3 O, L\u00f3pez S, Pons A, Bernardo M, Cardellach F (2007) Neuroleptic treatment effect on mitochondrial electron transport chain: peripheral blood mononuclear cells analysis in psychotic patients. J Clin Psychopharmacol 27:284\u2013288. https:\/\/doi.org\/10.1097\/JCP.0b013e318054753e","journal-title":"J Clin Psychopharmacol"},{"key":"1665_CR6","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1111\/j.1476-5381.1983.tb09419.x","volume":"78","author":"MK Church","year":"1983","unstructured":"Church MK, Young KD (1983) The characteristics of inhibition of histamine release from human lung fragments by sodium cromoglycate, salbutamol and chlorpromazine. Br J Pharmacol 78:671\u2013679","journal-title":"Br J Pharmacol"},{"key":"1665_CR7","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2018.00144","volume":"9","author":"A Del Campo","year":"2018","unstructured":"Del Campo A, Bustos C, Mascayano C, Acu\u00f1a-Castillo C, Troncoso R, Rojo LE (2018) Metabolic syndrome and antipsychotics: the role of mitochondrial fission\/fusion imbalance. Front Endocrinol (Lausanne) 9:144. https:\/\/doi.org\/10.3389\/fendo.2018.00144","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1665_CR8","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1038\/nature10330","volume":"476","author":"RG Efremov","year":"2011","unstructured":"Efremov RG, Sazanov LA (2011) Structure of the membrane domain of respiratory complex I. Nature 476:414\u2013420. https:\/\/doi.org\/10.1038\/nature10330","journal-title":"Nature"},{"key":"1665_CR9","doi-asserted-by":"publisher","first-page":"369","DOI":"10.3109\/00498254.2015.1078522","volume":"46","author":"A Eftekhari","year":"2016","unstructured":"Eftekhari A, Azarmi Y, Parvizpur A, Eghbal MA (2016) Involvement of oxidative stress and mitochondrial\/lysosomal cross-talk in olanzapine cytotoxicity in freshly isolated rat hepatocytes. Xenobiotica 46:369\u2013378. https:\/\/doi.org\/10.3109\/00498254.2015.1078522","journal-title":"Xenobiotica"},{"key":"1665_CR10","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1093\/oxfordjournals.schbul.a033414","volume":"25","author":"AM Elkashef","year":"1999","unstructured":"Elkashef AM, Wyatt RJ (1999) Tardive dyskinesia: possible involvement of free radicals and treatment with vitamin E. Schizophr Bull 25:731\u2013740","journal-title":"Schizophr Bull"},{"key":"1665_CR11","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.toxlet.2017.03.018","volume":"272","author":"E Elmorsy","year":"2017","unstructured":"Elmorsy E, Al-Ghafari A, Aggour AM, Mosad SM, Khan R, Amer S (2017) Effect of antipsychotics on mitochondrial bioenergetics of rat ovarian theca cells. Toxicol Lett 272:94\u2013100. https:\/\/doi.org\/10.1016\/j.toxlet.2017.03.018","journal-title":"Toxicol Lett"},{"key":"1665_CR12","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1016\/j.tcb.2018.06.006","volume":"28","author":"K Fiedorczuk","year":"2018","unstructured":"Fiedorczuk K, Sazanov LA (2018) Mammalian mitochondrial complex I structure and disease-causing mutations. Trends Cell Biol 28:835\u2013867. https:\/\/doi.org\/10.1016\/j.tcb.2018.06.006","journal-title":"Trends Cell Biol"},{"key":"1665_CR13","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1038\/nature19794","volume":"538","author":"K Fiedorczuk","year":"2016","unstructured":"Fiedorczuk K, Letts JA, Degliesposti G, Kaszuba K, Skehel M, Sazanov LA (2016) Atomic structure of the entire mammalian mitochondrial complex I. Nature 538:406\u2013410. https:\/\/doi.org\/10.1038\/nature19794","journal-title":"Nature"},{"key":"1665_CR14","doi-asserted-by":"crossref","first-page":"15","DOI":"10.14712\/fb2016062010015","volume":"62","author":"Z Fi\u0161ar","year":"2016","unstructured":"Fi\u0161ar Z, Hroudov\u00e1 J (2016) Pig brain mitochondria as a biological model for study of mitochondrial respiration. Folia Biol (Praha) 62:15\u201325","journal-title":"Folia Biol (Praha)"},{"key":"1665_CR15","first-page":"645","volume":"31","author":"Z Fi\u0161ar","year":"2010","unstructured":"Fi\u0161ar Z, Hroudov\u00e1 J, Raboch J (2010) Inhibition of monoamine oxidase activity by antidepressants and mood stabilizers. Neuro Endocrinol Lett 31:645\u2013656","journal-title":"Neuro Endocrinol Lett"},{"key":"1665_CR16","doi-asserted-by":"publisher","first-page":"930","DOI":"10.2174\/1567205013666160314150856","volume":"13","author":"Z Fi\u0161ar","year":"2016","unstructured":"Fi\u0161ar Z et al (2016a) Mitochondrial respiration in the platelets of patients with Alzheimer's disease. Curr Alzheimer Res 13:930\u2013941","journal-title":"Curr Alzheimer Res"},{"key":"1665_CR17","doi-asserted-by":"crossref","first-page":"53","DOI":"10.14712\/fb2016062020053","volume":"62","author":"Z Fi\u0161ar","year":"2016","unstructured":"Fi\u0161ar Z, Hroudov\u00e1 J, Singh N, Kop\u0159ivov\u00e1 A, Mace\u010dkov\u00e1 D (2016b) Effect of simvastatin, coenzyme Q10, resveratrol, acetylcysteine and acetylcarnitine on mitochondrial respiration. Folia Biol (Praha) 62:53\u201366","journal-title":"Folia Biol (Praha)"},{"key":"1665_CR18","first-page":"258","volume":"54","author":"Z Fi\u0161ar","year":"2017","unstructured":"Fi\u0161ar Z, Hroudov\u00e1 J, Singh N, Mace\u010dkov\u00e1 D, Kop\u0159ivov\u00e1 A (2017) Protocols for high-resolution respirometry experiments to test the activity of electron transfer system of pig brain mitochondria. Indian J Biochem Biophys 54:258\u2013272","journal-title":"Indian J Biochem Biophys"},{"key":"1665_CR19","doi-asserted-by":"publisher","unstructured":"Fi\u0161ar Z, Jir\u00e1k R, Zv\u011b\u0159ov\u00e1 M, Setni\u010dka V, Habartov\u00e1 L, Hroudov\u00e1 J, Van\u00ed\u010dkov\u00e1 Z, Raboch J (2019) Plasma amyloid beta levels and platelet mitochondrial respiration in patients with Alzheimer's disease. Clin Biochem. https:\/\/doi.org\/10.1016\/j.clinbiochem.2019.04.003","DOI":"10.1016\/j.clinbiochem.2019.04.003"},{"key":"1665_CR20","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/j.neuint.2009.11.011","volume":"56","author":"J Folbergrov\u00e1","year":"2010","unstructured":"Folbergrov\u00e1 J, Je\u0161ina P, Haugvicov\u00e1 R, Lis\u00fd V, Hou\u0161t\u011bk J (2010) Sustained deficiency of mitochondrial complex I activity during long periods of survival after seizures induced in immature rats by homocysteic acid. Neurochem Int 56:394\u2013403. https:\/\/doi.org\/10.1016\/j.neuint.2009.11.011","journal-title":"Neurochem Int"},{"key":"1665_CR21","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.1176\/appi.ajp.158.11.1774","volume":"158","author":"AH Glassman","year":"2001","unstructured":"Glassman AH, Bigger JT (2001) Antipsychotic drugs: prolonged QTc interval, torsade de pointes, and sudden death. Am J Psychiatry 158:1774\u20131782. https:\/\/doi.org\/10.1176\/appi.ajp.158.11.1774","journal-title":"Am J Psychiatry"},{"key":"1665_CR22","doi-asserted-by":"publisher","first-page":"1730","DOI":"10.1176\/ajp.152.5.815","volume":"152","author":"DC Goff","year":"1995","unstructured":"Goff DC, Tsai G, Beal MF, Coyle JT (1995) Tardive dyskinesia and substrates of energy metabolism in CSF. Am J Psychiatry 152:1730\u20131736. https:\/\/doi.org\/10.1176\/ajp.152.12.1730","journal-title":"Am J Psychiatry"},{"key":"1665_CR23","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.2165\/00003495-200262110-00006","volume":"62","author":"PM Haddad","year":"2002","unstructured":"Haddad PM, Anderson IM (2002) Antipsychotic-related QTc prolongation, torsade de pointes and sudden death. Drugs 62:1649\u20131671","journal-title":"Drugs"},{"key":"1665_CR24","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1055\/s-0043-116492","volume":"51","author":"C Hiemke","year":"2018","unstructured":"Hiemke C, Bergemann N, Clement H, Conca A, Deckert J, Domschke K, Eckermann G, Egberts K, Gerlach M, Greiner C, Gr\u00fcnder G, Haen E, Havemann-Reinecke U, Hefner G, Helmer R, Janssen G, Jaquenoud E, Laux G, Messer T, M\u00f6ssner R, M\u00fcller M, Paulzen M, Pfuhlmann B, Riederer P, Saria A, Schoppek B, Schoretsanitis G, Schwarz M, Gracia M, Stegmann B, Steimer W, Stingl J, Uhr M, Ulrich S, Unterecker S, Waschgler R, Zernig G, Zurek G, Baumann P (2018) Consensus guidelines for therapeutic drug monitoring in Neuropsychopharmacology: update 2017. Pharmacopsychiatry 51:9\u201362. https:\/\/doi.org\/10.1055\/s-0043-116492","journal-title":"Pharmacopsychiatry"},{"key":"1665_CR25","first-page":"336","volume":"31","author":"J Hroudova","year":"2010","unstructured":"Hroudova J, Fisar Z (2010) Activities of respiratory chain complexes and citrate synthase influenced by pharmacologically different antidepressants and mood stabilizers. Neuro Endocrinol Lett 31:336\u2013342","journal-title":"Neuro Endocrinol Lett"},{"key":"1665_CR26","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.toxlet.2012.07.017","volume":"213","author":"J Hroudov\u00e1","year":"2012","unstructured":"Hroudov\u00e1 J, Fi\u0161ar Z (2012) In vitro inhibition of mitochondrial respiratory rate by antidepressants. Toxicol Lett 213:345\u2013352. https:\/\/doi.org\/10.1016\/j.toxlet.2012.07.017","journal-title":"Toxicol Lett"},{"key":"1665_CR27","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/S0969-2126(00)00152-0","volume":"8","author":"C Hunte","year":"2000","unstructured":"Hunte C, Koepke J, Lange C, Rossmanith T, Michel H (2000) Structure at 2.3\u00a0\u00c5 resolution of the cytochrome bc(1) complex from the yeast Saccharomyces cerevisiae co-crystallized with an antibody Fv fragment. Structure 8:669\u2013684","journal-title":"Structure"},{"key":"1665_CR28","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1007\/400_2007_042","volume":"45","author":"C Hunte","year":"2008","unstructured":"Hunte C, Solmaz S, Palsdottir H, Wenz T (2008) A structural perspective on mechanism and function of the cytochrome bc (1) complex. Results Probl Cell Differ 45:253\u2013278. https:\/\/doi.org\/10.1007\/400_2007_042","journal-title":"Results Probl Cell Differ"},{"key":"1665_CR29","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1016\/j.bbabio.2012.09.008","volume":"1827","author":"TM Iverson","year":"2013","unstructured":"Iverson TM (2013) Catalytic mechanisms of complex II enzymes: a structural perspective. Biochim Biophys Acta 1827:648\u2013657. https:\/\/doi.org\/10.1016\/j.bbabio.2012.09.008","journal-title":"Biochim Biophys Acta"},{"key":"1665_CR30","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1126\/science.281.5373.64","volume":"281","author":"S Iwata","year":"1998","unstructured":"Iwata S, Lee JW, Okada K, Lee JK, Iwata M, Rasmussen B, Link TA, Ramaswamy S, Jap BK (1998) Complete structure of the 11-subunit bovine mitochondrial cytochrome bc1 complex. Science 281:64\u201371","journal-title":"Science"},{"key":"1665_CR31","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1111\/j.1471-4159.2011.07590.x","volume":"120","author":"S Jafari","year":"2012","unstructured":"Jafari S, Fernandez-Enright F, Huang XF (2012) Structural contributions of antipsychotic drugs to their therapeutic profiles and metabolic side effects. J Neurochem 120:371\u2013384. https:\/\/doi.org\/10.1111\/j.1471-4159.2011.07590.x","journal-title":"J Neurochem"},{"key":"1665_CR32","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1176\/appi.ajp.158.3.360","volume":"158","author":"S Kapur","year":"2001","unstructured":"Kapur S, Seeman P (2001) Does fast dissociation from the dopamine d(2) receptor explain the action of atypical antipsychotics?: a new hypothesis. Am J Psychiatry 158:360\u2013369. https:\/\/doi.org\/10.1176\/appi.ajp.158.3.360","journal-title":"Am J Psychiatry"},{"key":"1665_CR33","first-page":"S46","volume":"39","author":"D Keegan","year":"1994","unstructured":"Keegan D (1994) Risperidone: neurochemical, pharmacologic and clinical properties of a new antipsychotic drug. Can J Psychiatr 39:S46\u2013S52","journal-title":"Can J Psychiatr"},{"key":"1665_CR34","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1038\/nsmb.3460","volume":"24","author":"JA Letts","year":"2017","unstructured":"Letts JA, Sazanov LA (2017) Clarifying the supercomplex: the higher-order organization of the mitochondrial electron transport chain. Nat Struct Mol Biol 24:800\u2013808. https:\/\/doi.org\/10.1038\/nsmb.3460","journal-title":"Nat Struct Mol Biol"},{"key":"1665_CR35","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/S0140-6736(08)61764-X","volume":"373","author":"S Leucht","year":"2009","unstructured":"Leucht S, Corves C, Arbter D, Engel RR, Li C, Davis JM (2009) Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis. Lancet 373:31\u201341. https:\/\/doi.org\/10.1016\/S0140-6736(08)61764-X","journal-title":"Lancet"},{"key":"1665_CR36","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1016\/S0140-6736(13)60733-3","volume":"382","author":"S Leucht","year":"2013","unstructured":"Leucht S, Cipriani A, Spineli L, Mavridis D, \u00d6rey D, Richter F, Samara M, Barbui C, Engel RR, Geddes JR, Kissling W, Stapf MP, L\u00e4ssig B, Salanti G, Davis JM (2013) Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis. Lancet 382:951\u2013962. https:\/\/doi.org\/10.1016\/S0140-6736(13)60733-3","journal-title":"Lancet"},{"key":"1665_CR37","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1056\/NEJMoa051688","volume":"353","author":"JA Lieberman","year":"2005","unstructured":"Lieberman JA, Stroup TS, McEvoy J, Swartz MS, Rosenheck RA, Perkins DO, Keefe RS, Davis SM, Davis CE, Lebowitz BD, Severe J, Hsiao JK, Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Investigators (2005) Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Engl J Med 353:1209\u20131223. https:\/\/doi.org\/10.1056\/NEJMoa051688","journal-title":"N Engl J Med"},{"key":"1665_CR38","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","volume":"193","author":"OH Lowry","year":"1951","unstructured":"Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265\u2013275","journal-title":"J Biol Chem"},{"issue":"suppl14","key":"1665_CR39","first-page":"11","volume":"10","author":"PS Masand","year":"2005","unstructured":"Masand PS, Culpepper L, Henderson D, Lee S, Littrell K, Newcomer JW, Rasgon N (2005) Metabolic and endocrine disturbances in psychiatric disorders: a multidisciplinary approach to appropriate atypical antipsychotic utilization. CNS spectrums 10(suppl14):11\u201315","journal-title":"CNS spectrums"},{"key":"1665_CR40","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1023\/A:1006872911332","volume":"174","author":"I Maurer","year":"1997","unstructured":"Maurer I, M\u00f6ller HJ (1997) Inhibition of complex I by neuroleptics in normal human brain cortex parallels the extrapyramidal toxicity of neuroleptics. Mol Cell Biochem 174:255\u2013259","journal-title":"Mol Cell Biochem"},{"key":"1665_CR41","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1055\/s-0031-1300116","volume":"51","author":"I Maurer","year":"2001","unstructured":"Maurer I, Volz HP (2001) Cell-mediated side effects of psychopharmacological treatment. Arzneimittelforschung 51:785\u2013792. https:\/\/doi.org\/10.1055\/s-0031-1300116","journal-title":"Arzneimittelforschung"},{"key":"1665_CR42","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/S0920-9964(00)00075-X","volume":"48","author":"I Maurer","year":"2001","unstructured":"Maurer I, Zierz S, Moller H (2001) Evidence for a mitochondrial oxidative phosphorylation defect in brains from patients with schizophrenia. Schizophr Res 48:125\u2013136","journal-title":"Schizophr Res"},{"key":"1665_CR43","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1007\/BF02980205","volume":"26","author":"JS Modica-Napolitano","year":"2003","unstructured":"Modica-Napolitano JS, Lagace CJ, Brennan WA, Aprille JR (2003) Differential effects of typical and atypical neuroleptics on mitochondrial function in vitro. Arch Pharm Res 26:951\u2013959","journal-title":"Arch Pharm Res"},{"key":"1665_CR44","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/sj.mp.4002066","volume":"13","author":"HA Nasrallah","year":"2008","unstructured":"Nasrallah HA (2008) Atypical antipsychotic-induced metabolic side effects: insights from receptor-binding profiles. Mol Psychiatry 13:27\u201335. https:\/\/doi.org\/10.1038\/sj.mp.4002066","journal-title":"Mol Psychiatry"},{"key":"1665_CR45","unstructured":"Noda K, Suzuki A, Okui M, Noguchi H, Nishiura M, Nishiura N (1979) Pharmacokinetics and metabolism of 2-chloro-11-(2-dimethylaminoethoxy)-dibenzo[b,f]thiepine (zotepine) in rat, mouse, dog and man Arzneimittelforschung 29:1595\u20131600"},{"key":"1665_CR46","doi-asserted-by":"publisher","first-page":"37568","DOI":"10.18632\/oncotarget.17247","volume":"8","author":"CR Oliva","year":"2017","unstructured":"Oliva CR, Zhang W, Langford C, Suto MJ, Griguer CE (2017) Repositioning chlorpromazine for treating chemoresistant glioma through the inhibition of cytochrome c oxidase bearing the COX4-1 regulatory subunit. Oncotarget 8:37568\u201337583. https:\/\/doi.org\/10.18632\/oncotarget.17247","journal-title":"Oncotarget"},{"key":"1665_CR47","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1007\/s00702-012-0782-2","volume":"119","author":"A Ota","year":"2012","unstructured":"Ota A, Nakashima A, Kaneko YS, Mori K, Nagasaki H, Takayanagi T, Itoh M, Kondo K, Nagatsu T, Ota M (2012) Effects of aripiprazole and clozapine on the treatment of glycolytic carbon in PC12 cells. J Neural Transm (Vienna) 119:1327\u20131342. https:\/\/doi.org\/10.1007\/s00702-012-0782-2","journal-title":"J Neural Transm (Vienna)"},{"key":"1665_CR48","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1016\/j.bbabio.2008.05.443","volume":"1777","author":"RU Pathak","year":"2008","unstructured":"Pathak RU, Davey GP (2008) Complex I and energy thresholds in the brain. Biochim Biophys Acta 1777:777\u2013782. https:\/\/doi.org\/10.1016\/j.bbabio.2008.05.443","journal-title":"Biochim Biophys Acta"},{"key":"1665_CR49","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/978-1-61779-382-0_3","volume":"810","author":"D Pesta","year":"2012","unstructured":"Pesta D, Gnaiger E (2012) High-resolution respirometry: OXPHOS protocols for human cells and permeabilized fibers from small biopsies of human muscle. Methods Mol Biol 810:25\u201358. https:\/\/doi.org\/10.1007\/978-1-61779-382-0_3","journal-title":"Methods Mol Biol"},{"key":"1665_CR50","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1016\/S0006-3223(03)00414-1","volume":"54","author":"G Pinna","year":"2003","unstructured":"Pinna G, Broedel O, Eravci M, Stoltenburg-Didinger G, Plueckhan H, Fuxius S, Meinhold H, Baumgartner A (2003) Thyroid hormones in the rat amygdala as common targets for antidepressant drugs, mood stabilizers, and sleep deprivation. Biol Psychiatry 54:1049\u20131059","journal-title":"Biol Psychiatry"},{"key":"1665_CR51","first-page":"261","volume":"280","author":"JA Prince","year":"1997","unstructured":"Prince JA, Yassin MS, Oreland L (1997) Neuroleptic-induced mitochondrial enzyme alterations in the rat brain. J Pharmacol Exp Ther 280:261\u2013267","journal-title":"J Pharmacol Exp Ther"},{"key":"1665_CR52","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0100054","volume":"9","author":"MW Rice","year":"2014","unstructured":"Rice MW, Smith KL, Roberts RC, Perez-Costas E, Melendez-Ferro M (2014) Assessment of cytochrome C oxidase dysfunction in the substantia nigra\/ventral tegmental area in schizophrenia. PLoS One 9:e100054. https:\/\/doi.org\/10.1371\/journal.pone.0100054","journal-title":"PLoS One"},{"key":"1665_CR53","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.schres.2017.01.056","volume":"187","author":"RC Roberts","year":"2017","unstructured":"Roberts RC (2017) Postmortem studies on mitochondria in schizophrenia. Schizophr Res 187:17\u201325. https:\/\/doi.org\/10.1016\/j.schres.2017.01.056","journal-title":"Schizophr Res"},{"key":"1665_CR54","doi-asserted-by":"publisher","unstructured":"Robertson OD, Coronado NG, Sethi R, Berk M, Dodd S (2019) Putative neuroprotective pharmacotherapies to target the staged progression of mental illness. Early Interv Psychiatry. https:\/\/doi.org\/10.1111\/eip.12775","DOI":"10.1111\/eip.12775"},{"key":"1665_CR55","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/0009-8981(94)90055-8","volume":"228","author":"P Rustin","year":"1994","unstructured":"Rustin P, Chretien D, Bourgeron T, Gerard B, Rotig A, Saudubray JM, Munnich A (1994) Biochemical and molecular investigations in respiratory chain deficiencies. Clin Chim Acta: Int J Clin Chem 228:35\u201351","journal-title":"Clin Chim Acta: Int J Clin Chem"},{"key":"1665_CR56","unstructured":"Sangani A, Saadabadi A (2019) Neuroleptic medications. In: StatPearls. Treasure Island (FL),"},{"key":"1665_CR57","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.euroneuro.2018.01.004","volume":"28","author":"G Scaini","year":"2018","unstructured":"Scaini G, Quevedo J, Velligan D, Roberts DL, Raventos H, Walss-Bass C (2018) Second generation antipsychotic-induced mitochondrial alterations: implications for increased risk of metabolic syndrome in patients with schizophrenia. Eur Neuropsychopharmacol 28:369\u2013380. https:\/\/doi.org\/10.1016\/j.euroneuro.2018.01.004","journal-title":"Eur Neuropsychopharmacol"},{"key":"1665_CR58","doi-asserted-by":"publisher","first-page":"C12","DOI":"10.1152\/ajpcell.00314.2006","volume":"293","author":"R Scatena","year":"2007","unstructured":"Scatena R, Bottoni P, Botta G, Martorana GE, Giardina B (2007) The role of mitochondria in pharmacotoxicology: a reevaluation of an old, newly emerging topic. Am J Phys Cell Phys 293:C12\u2013C21. https:\/\/doi.org\/10.1152\/ajpcell.00314.2006","journal-title":"Am J Phys Cell Phys"},{"key":"1665_CR59","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/S0005-2728(98)00032-2","volume":"1364","author":"AH Schapira","year":"1998","unstructured":"Schapira AH (1998) Human complex I defects in neurodegenerative diseases. Biochim Biophys Acta 1364:261\u2013270","journal-title":"Biochim Biophys Acta"},{"key":"1665_CR60","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1177\/070674370204700106","volume":"47","author":"P Seeman","year":"2002","unstructured":"Seeman P (2002) Atypical antipsychotics: mechanism of action. Can J Psychiatr 47:27\u201338","journal-title":"Can J Psychiatr"},{"key":"1665_CR61","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/978-981-10-7757-9_7","volume":"87","author":"JS Sousa","year":"2018","unstructured":"Sousa JS, D'Imprima E, Vonck J (2018) Mitochondrial respiratory chain complexes. Subcell Biochem 87:167\u2013227. https:\/\/doi.org\/10.1007\/978-981-10-7757-9_7","journal-title":"Subcell Biochem"},{"key":"1665_CR62","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1007\/s00406-018-0880-8","volume":"268","author":"I Spellmann","year":"2018","unstructured":"Spellmann I, Reinhard MA, Veverka D, Zill P, Obermeier M, Dehning S, Schennach R, M\u00fcller N, M\u00f6ller HJ, Riedel M, Musil R (2018) QTc prolongation in short-term treatment of schizophrenia patients: effects of different antipsychotics and genetic factors. Eur Arch Psychiatry Clin Neurosci 268:383\u2013390. https:\/\/doi.org\/10.1007\/s00406-018-0880-8","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"1665_CR63","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/0076-6879(69)13005-0","volume":"13","author":"Srere","year":"1969","unstructured":"Srere (1969) Citrate synthase: [EC 4.1.3.7 citrate oxaloacetate-lyase (CoA acetylating). Methods Enzymol 13:3\u201311","journal-title":"Methods Enzymol"},{"key":"1665_CR64","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/s00210-007-0178-2","volume":"376","author":"EL Streck","year":"2007","unstructured":"Streck EL, Rezin GT, Barbosa LM, Assis LC, Grandi E, Quevedo J (2007) Effect of antipsychotics on succinate dehydrogenase and cytochrome oxidase activities in rat brain. Naunyn Schmiedeberg's Arch Pharmacol 376:127\u2013133. https:\/\/doi.org\/10.1007\/s00210-007-0178-2","journal-title":"Naunyn Schmiedeberg's Arch Pharmacol"},{"key":"1665_CR65","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1016\/j.cell.2005.05.025","volume":"121","author":"F Sun","year":"2005","unstructured":"Sun F, Huo X, Zhai Y, Wang A, Xu J, Su D, Bartlam M, Rao Z (2005) Crystal structure of mitochondrial respiratory membrane protein complex II. Cell 121:1043\u20131057. https:\/\/doi.org\/10.1016\/j.cell.2005.05.025","journal-title":"Cell"},{"key":"1665_CR66","doi-asserted-by":"publisher","first-page":"423","DOI":"10.2165\/00023210-200317060-00004","volume":"17","author":"D Taylor","year":"2003","unstructured":"Taylor D (2003a) Ziprasidone in the management of schizophrenia: the QT interval issue in context. CNS Drugs 17:423\u2013430","journal-title":"CNS Drugs"},{"key":"1665_CR67","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1034\/j.1600-0447.2003.02078.x","volume":"107","author":"DM Taylor","year":"2003","unstructured":"Taylor DM (2003b) Antipsychotics and QT prolongation. Acta Psychiatr Scand 107:85\u201395","journal-title":"Acta Psychiatr Scand"},{"key":"1665_CR68","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1038\/249664a0","volume":"249","author":"M Trabucchi","year":"1974","unstructured":"Trabucchi M, Cheney D, Racagni G, Costa E (1974) Involvement of brain cholinergic mechanisms in the action of chlorpromazine. Nature 249:664\u2013666","journal-title":"Nature"},{"key":"1665_CR69","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/S0076-6879(96)64044-0","volume":"264","author":"IA Trounce","year":"1996","unstructured":"Trounce IA, Kim YL, Jun AS, Wallace DC (1996) Assessment of mitochondrial oxidative phosphorylation in patient muscle biopsies, lymphoblasts, and transmitochondrial cell lines. Methods Enzymol 264:484\u2013509","journal-title":"Methods Enzymol"},{"key":"1665_CR70","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1126\/science.7652554","volume":"269","author":"T Tsukihara","year":"1995","unstructured":"Tsukihara T, Aoyama H, Yamashita E, Tomizaki T, Yamaguchi H, Shinzawa-Itoh K, Nakashima R, Yaono R, Yoshikawa S (1995) Structures of metal sites of oxidized bovine heart cytochrome c oxidase at 2.8\u00a0\u00c5. Science 269:1069\u20131074","journal-title":"Science"},{"key":"1665_CR71","doi-asserted-by":"publisher","first-page":"205","DOI":"10.4088\/PCC.v05n0504","volume":"5","author":"WV Vieweg","year":"2003","unstructured":"Vieweg WV (2003) New generation antipsychotic drugs and QTc interval prolongation. Prim Care Companion J Clin Psychiatry 5:205\u2013215","journal-title":"Prim Care Companion J Clin Psychiatry"},{"key":"1665_CR72","doi-asserted-by":"publisher","first-page":"2362","DOI":"10.4161\/15548627.2014.984270","volume":"10","author":"L Vucicevic","year":"2014","unstructured":"Vucicevic L, Misirkic-Marjanovic M, Paunovic V, Kravic-Stevovic T, Martinovic T, Ciric D, Maric N, Petricevic S, Harhaji-Trajkovic L, Bumbasirevic V, Trajkovic V (2014) Autophagy inhibition uncovers the neurotoxic action of the antipsychotic drug olanzapine. Autophagy 10:2362\u20132378. https:\/\/doi.org\/10.4161\/15548627.2014.984270","journal-title":"Autophagy"},{"issue":"Suppl 21","key":"1665_CR73","first-page":"15","volume":"62","author":"WC Wirshing","year":"2001","unstructured":"Wirshing WC (2001) Movement disorders associated with neuroleptic treatment. J Clin Psychiatry 62(Suppl 21):15\u201318","journal-title":"J Clin Psychiatry"},{"key":"1665_CR74","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/0166-2236(89)90165-3","volume":"12","author":"MT Wong-Riley","year":"1989","unstructured":"Wong-Riley MT (1989) Cytochrome oxidase: an endogenous metabolic marker for neuronal activity. Trends Neurosci 12:94\u2013101","journal-title":"Trends Neurosci"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-019-01665-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00210-019-01665-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-019-01665-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,18]],"date-time":"2024-07-18T07:32:12Z","timestamp":1721287932000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00210-019-01665-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,19]]},"references-count":74,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["1665"],"URL":"https:\/\/doi.org\/10.1007\/s00210-019-01665-8","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,19]]},"assertion":[{"value":"11 April 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that there is no conflict of interest regarding the publication of this paper.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}